- Home
- SEER vs LFCR Comparison
SEER vs LFCR Comparison
Compare SEER & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- LFCR
- Stock Information
- Founded
- SEER 2017
- LFCR 1986
- Country
- SEER United States
- LFCR United States
- Employees
- SEER N/A
- LFCR N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- SEER Health Care
- LFCR Health Care
- Exchange
- SEER Nasdaq
- LFCR Nasdaq
- Market Cap
- SEER 105.0M
- LFCR 117.9M
- IPO Year
- SEER 2020
- LFCR N/A
- Fundamental
- Price
- SEER $1.69
- LFCR $5.05
- Analyst Decision
- SEER Hold
- LFCR Buy
- Analyst Count
- SEER 1
- LFCR 2
- Target Price
- SEER $3.00
- LFCR $8.00
- AVG Volume (30 Days)
- SEER 296.7K
- LFCR 407.6K
- Earning Date
- SEER 11-05-2024
- LFCR 08-26-2024
- Dividend Yield
- SEER N/A
- LFCR N/A
- EPS Growth
- SEER N/A
- LFCR N/A
- EPS
- SEER N/A
- LFCR 0.32
- Revenue
- SEER $14,738,000.00
- LFCR $128,261,000.00
- Revenue This Year
- SEER N/A
- LFCR $1.82
- Revenue Next Year
- SEER $43.19
- LFCR $9.10
- P/E Ratio
- SEER N/A
- LFCR $20.72
- Revenue Growth
- SEER N/A
- LFCR 24.20
- 52 Week Low
- SEER $1.46
- LFCR $3.68
- 52 Week High
- SEER $2.62
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- SEER 53.32
- LFCR 51.97
- Support Level
- SEER $1.59
- LFCR $4.62
- Resistance Level
- SEER $1.73
- LFCR $5.27
- Average True Range (ATR)
- SEER 0.06
- LFCR 0.49
- MACD
- SEER 0.01
- LFCR 0.07
- Stochastic Oscillator
- SEER 71.43
- LFCR 66.44
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.